Center for Childhood Cancer Research The Center for Childhood Cancer Research represents a highly integrated basic, translational and clinical research environment dedicated to eradicating the pain and suffering caused by cancer in children. Learn more about the CCCR
Pediatric Cancers Differ from Adult Cancers, and Need Different Treatment Plans, Say CHOP Experts A new study finds important differences in how cancers develop in children as compared to adults, proving the concept that childhood cancers are not "small adult tumors." View more
FDA Approves Personalized Cellular Therapy for Advanced Leukemia Developed by University of Pennsylvania and Children’s Hospital of PhiladelphiaThis is a game changer for the treatment of pediatric patients battling leukemia and a pivotal milestone in this new era of cellular therapies that treat cancer with a patient’s own immune system. T-cell Therapy Pioneered at CHOP Shows Persistent Benefits in Young Leukemia PatientsUpdated results from a global clinical trial of the CAR T-cell therapy for ALL reveal that children and young adults continued to show high rates of durable, complete remission of their disease. CHOP Researchers Identify Potential Target in Treating High-risk Childhood CancersOncology researchers studying high-risk children’s cancers have identified a cell surface protein that may offer an important target for immunotherapy, a treatment that has the potential to zero in on cancer cells without harming healthy cells.